InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Lund- Jürgensen Kirsten, 管理人员. Officer active across 1 company, notably UCB. Aggregated, 7 filings have been logged. History available since 2 October 2025. The latest transaction was filed on 10 April 2026 (Sale). Regulator: FSMA. All data is accessible without signup.
Companies and markets linked to Lund- Jürgensen Kirsten
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
3,084 股@ €270.890.0019% mcap22.3% 占其流量ShareEuronext BrusselsISIN BE0003739530FSMA:ucb-126
3,084 股0ShareOff exchangeISIN BE0003739530FSMA:ucb-225
2,549 股0Options /warrants for employees or managersOff exchangeFSMA:ucb-18
3,660 股@ €287.2928.1% 占其流量ShareEuronext BrusselsISIN BE0003739530FSMA:ucb-125
3,615 股@ €287.290.0% 占其流量ShareEuronext BrusselsISIN BE0003739530FSMA:ucb-9
3,682 股@ €287.2928.2% 占其流量ShareEuronext BrusselsISIN BE0003739530FSMA:ucb-181
5,746 股@ €139.4521.4% 占其流量OtherOff exchangeFSMA:ucb-31
7 条申报中的 7 条
About Lund- Jürgensen Kirsten
Kirsten Lund-Jürgensen is a senior executive at UCB, a biopharmaceutical company. She is responsible for managing operations and product innovation. Her expertise contributes to the growth and reputation of UCB in the market.
